-
Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure
- 2025/02/04
- 再生時間: 24 分
- ポッドキャスト
-
サマリー
あらすじ・解説
Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
activate_buybox_copy_target_t1